Efficacy of Adding Oral Simvastatin to Topical Therapy for Treatment of Psoriasis: The Vietnamese Experience

BACKGROUND: Psoriasis, the prevalence of which ranges from 2% to 3% of the general population, has been recently recognised as not only a chronic inflammatory skin disorder but also an immunometabolic systemic disease. Dyslipidemia is one of the most important comorbidities of psoriasis. Statins, fr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Access Maced J Med Sci
Autori principali: Trong, Hao Nguyen, Tat, Thang Nguyen, Anh, Tu Tran Nguyen, Uyen, Nhi Pham, Van, Thuong Nguyen, Hau, Khang Tran, Gandolfi, Marco, Satolli, Francesca, Feliciani, Claudio, Tirant, Michael, Vojvodic, Aleksandra, Lotti, Torello
Natura: Artigo
Lingua:Inglês
Pubblicazione: Republic of Macedonia 2019
Soggetti:
Clinical Science
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6364708/
https://ncbi.nlm.nih.gov/pubmed/30745969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3889/oamjms.2019.060
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi